Back
GT Biopharma 10K Form
Sell
33
GTBP
GT Biopharma
Last Price:
2.88
Seasonality Move:
4.16%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GTBP News And Ratings
See the #1 stock for the next 7 days that we like better than GTBP
GTBP Financial Statistics
Sales & Book Value
Annual Sales: | $27K |
---|---|
Cash Flow: | $-4.16M |
Price / Cash Flow: | 0 |
Annual Sales: | $3.85 |
Price / Book: | 0.77 |
Profitability
EPS (TTM): | -6.92360 |
---|---|
Net Income (TTM): | $-9.64M |
Gross Margin: | $0 |
Return on Equity: | 0% |
Return on Assets: | 0% |
GT Biopharma Earnings Forecast
Key GT Biopharma Financial Ratios
- The Selling, General & Administrative Expenses for GTBP have been equal to 29,459.26% of Gross Profit Margin.
- The Interest Expense is -2.80% of Operating Income.
- Per Share Earnings over the last 40 years have been positive in 20 years.
GT Biopharma Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | GTBP |
Website: | gtbiopharma.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
GTBP Technical Analysis vs Fundamental Analysis
Sell
33
GT Biopharma (GTBP)
is a Sell
Is GT Biopharma a Buy or a Sell?
-
GT Biopharma stock is rated a Sell
The current GT Biopharma [GTBP] share price is $2.88. The Score for GTBP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.